A novel cell-based assay for the evaluation of immune- and inflammatory-related gene expression as biomarkers for the risk assessment of drug-induced liver injury-Reference-Cited by-同舟云学术

A novel cell-based assay for the evaluation of immune- and inflammatory-related gene expression as biomarkers for the risk assessment of drug-induced liver injury

Published:2016-01 Issue: Volume:241 Page:60-70
ISSN:0378-4274
Container-title:Toxicology Letters
language:en
Short-container-title:Toxicology Letters

Author:

Oda Shingo^ORCID,Matsuo Kentaro,Nakajima Akira,Yokoi Tsuyoshi

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference48 articles.

1. Mechanisms of immune-mediated liver injury;Adams;Toxicol. Sci.,2010

2. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells;Aninat;Drug Metab. Dispos.,2006

3. Troglitazone induces a rapid drop of mitochondrial membrane potential in liver HepG2 cells;Bova;Toxicol. Lett.,2005

4. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells;Chen;Nat. Med.,2007

5. FDA-approved drug labeling for the study of drug-induced liver injury;Chen;Drug Discov. Today,2011

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing immune hepatotoxicity of troglitazone with a versatile liver-immune-microphysiological-system;Frontiers in Pharmacology;2024-05-30

2. Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network;Journal of Hepatology;2024-05

3. Control Compounds for Preclinical Drug-Induced Liver Injury Assessment: Consensus-driven systematic review by the ProEuroDILI Network;2023-11-09

4. Mechanistic Understanding of Idiosyncratic Drug-Induced Hepatotoxicity Using Co-Cultures of Hepatocytes and Macrophages;Antioxidants;2023-06-21

5. Idiosyncratic Drug-Induced Liver Injury: From Pathogenesis to Risk Reduction;Safety and Risk of Pharmacotherapy;2023-06-19